Navigation Links
ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
Date:1/28/2009

Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a panel of top pharmaceutical financial experts in discussing "Methodologies for Managing Cash Flow and Accruals" at the CBI Forecasting & Budgeting conference. The panel will demonstrate practical ways to gain greater control over clinical trial budgets and improve management of clinical trial cash flow and accruals.

Chicago, IL (PRWEB) January 28, 2009 -- ClearTrial (www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a panel of top pharmaceutical financial experts in discussing "Methodologies for Managing Cash Flow and Accruals" at the CBI Forecasting & Budgeting conference. Held at the Crowne Plaza Hotel in Philadelphia, February 3-4, 2009, the conference will bring together senior biopharma executives in clinical operations and finance to share best practices.

With the complexity of clinical trials increasing, managing cash flow and accruals presents significant challenges to clinical operations and financial professionals at biopharma companies. The panel of experts will present proven guidelines for managing accruals in order to effectively manage clinical cash flow, including:

  • Obtaining accurate assessments of accruals based on actual work performed
  • Tracking contract performance and timelines
  • Accurately forecasting and managing one-time start-up fees
  • Effectively managing clinical cash flow

Lucas brings more than 15 years of experience in the pharmaceutical and biotech industry to the conference, with extensive experience in clinical trial budgeting and contract management. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at ICOS Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Lucas was responsible for establishing best practices in the outsourcing, management, drafting and negotiation of site and vendor agreements, as well as the development of a clinical budgeting/modeling application for lifecycle planning, budgeting and in-licensing opportunity assessment. Prior to ICOS, Lucas spent seven years with Genentech, where she was responsible for the negotiation, positioning, and pricing strategy for managed care contracts.

About ClearTrial®
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial's award-winning software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

###

Read the full story at http://www.prweb.com/releases/2009/01/prweb1923824.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE
2. Aegera Therapeutics phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
3. Metastorm Selected as a Finalist in ACG Deal of the Year Awards
4. Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System
5. NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device
6. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
7. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
8. Animetrics Inc. Selected to Provide 3D Face Viewer Technology for United States Army Biometric Automated Toolset (BAT)
9. Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
10. Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise
11. Cardium Selected for Inclusion in Russell Microcap Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has ... Making stops in several cities, she gained a number of delicious recipes and ... Stellenbosch, a town in South Africa’s Western Cape province. It is internationally renowned ...
(Date:2/24/2017)... PARSIPPANY, N.J. , Feb. 24, 2017 /PRNewswire/ ... botanicals and biotechnology are now the fastest growing ... the Specialty Actives in Personal Care: Multi-regional ... market research and management consulting firm Kline. ... using bioprocesses that make them more effective for ...
(Date:2/24/2017)... -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of ... reported its financial results for the fourth quarter and full ... 4Q16 record quarterly net sales of $1.13 billion, ... 4Q16 EMEA-APAC segment net sales ... Americas net sales increased 2.5%, or down 0.9% on an ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
Breaking Biology Technology:
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):